SEC CIK 1615258
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NATRview stock → | 0 | 2025-06-27 |
Position History — NATR
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NATR
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-06-27 | Open-market sale | 2,854,607 | $11.46 | 0 |
| 2024-10-15 | Open-market sale | 2,300 | $13.02 | 64,167 |
| 2024-10-14 | Open-market sale | 1,300 | $13.12 | 66,467 |
| 2024-10-11 | Open-market sale | 1,580 | $13.37 | 67,767 |
| 2024-10-10 | Open-market sale | 3,000 | $13.39 | 69,347 |
| 2024-10-09 | Open-market sale | 1,816 | $13.36 | 72,347 |
| 2024-10-08 | Open-market sale | 1,800 | $13.13 | 74,163 |
| 2024-10-01 | Open-market sale | 1,399 | $13.54 | 75,963 |
| 2024-09-06 | J | 2,968 | $0.00 | 77,362 |
| 2022-01-21 | J | 25,000 | $8.72 | 74,394 |
| 2022-01-07 | J | 9,558 | $0.00 | 49,394 |
| 2021-04-12 | J | 711 | $0.00 | 39,836 |
| 2019-12-11 | J | 14,125 | $0.00 | 14,125 |
| 2019-12-11 | J | 25,000 | $7.80 | 39,125 |
| 2014-07-25 | — | — | — | 2,854,607 |
| 2014-07-25 | — | — | — | 2,857,255 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.